Free Trial

Wealth Enhancement Advisory Services LLC Invests $394,000 in Siga Technologies Inc. $SIGA

Siga Technologies logo with Medical background

Key Points

  • Wealth Enhancement Advisory Services LLC invested approximately $394,000 in Siga Technologies Inc., acquiring 58,892 shares during the second quarter.
  • Siga Technologies' stock is currently trading at $8.23, reflecting a 8.0% decline, with a market cap of $589.35 million.
  • Analysts have mixed ratings on Siga Technologies, with one upgrading the stock from a "hold" to a "strong-buy" rating recently.
  • MarketBeat previews the top five stocks to own by November 1st.

Wealth Enhancement Advisory Services LLC purchased a new stake in Siga Technologies Inc. (NASDAQ:SIGA - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 58,892 shares of the company's stock, valued at approximately $394,000. Wealth Enhancement Advisory Services LLC owned 0.08% of Siga Technologies as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in the stock. Linden Thomas Advisory Services LLC grew its position in shares of Siga Technologies by 8.0% in the first quarter. Linden Thomas Advisory Services LLC now owns 26,230 shares of the company's stock valued at $144,000 after purchasing an additional 1,938 shares during the period. SummerHaven Investment Management LLC boosted its holdings in Siga Technologies by 2.6% in the 1st quarter. SummerHaven Investment Management LLC now owns 96,208 shares of the company's stock worth $527,000 after buying an additional 2,404 shares during the last quarter. Martingale Asset Management L P increased its stake in Siga Technologies by 3.2% during the 1st quarter. Martingale Asset Management L P now owns 86,157 shares of the company's stock worth $472,000 after buying an additional 2,684 shares in the last quarter. Uniplan Investment Counsel Inc. increased its stake in Siga Technologies by 0.7% during the 1st quarter. Uniplan Investment Counsel Inc. now owns 504,561 shares of the company's stock worth $2,765,000 after buying an additional 3,572 shares in the last quarter. Finally, Significant Wealth Partners LLC raised its holdings in shares of Siga Technologies by 21.4% during the first quarter. Significant Wealth Partners LLC now owns 34,269 shares of the company's stock valued at $188,000 after acquiring an additional 6,052 shares during the last quarter. 55.40% of the stock is currently owned by institutional investors and hedge funds.

Siga Technologies Trading Down 8.0%

Siga Technologies stock opened at $8.23 on Tuesday. The company has a 50-day moving average price of $8.51 and a 200 day moving average price of $6.98. Siga Technologies Inc. has a 12-month low of $4.95 and a 12-month high of $9.62. The stock has a market cap of $589.35 million, a P/E ratio of 7.28 and a beta of 0.96.

Siga Technologies (NASDAQ:SIGA - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.49 earnings per share for the quarter. The business had revenue of $81.12 million during the quarter. Siga Technologies had a net margin of 45.73% and a return on equity of 40.52%. As a group, analysts forecast that Siga Technologies Inc. will post 1.04 EPS for the current year.

Analyst Ratings Changes

SIGA has been the topic of a number of research analyst reports. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Siga Technologies in a research note on Saturday, September 27th. Wall Street Zen upgraded Siga Technologies from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 9th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, Siga Technologies presently has a consensus rating of "Hold".

View Our Latest Research Report on Siga Technologies

About Siga Technologies

(Free Report)

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Featured Stories

Institutional Ownership by Quarter for Siga Technologies (NASDAQ:SIGA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Siga Technologies Right Now?

Before you consider Siga Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Siga Technologies wasn't on the list.

While Siga Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.